Cited by 105Nanoparticle-Based Drug DeliveryAdvanced Drug Delivery SystemsBlood properties and coagulation

The effects of particle size, shape, density and flow characteristics on particle margination to vascular walls in cardiovascular diseases

Ta, Hang T., Truong, Nghia P., Whittaker, Andrew K., Davis, Thomas P., Peter, Karlheinz·2018·Expert Opinion on Drug Delivery

Abstract

INTRODUCTION: Vascular-targeted drug delivery is a promising approach for the treatment of atherosclerosis, due to the vast involvement of endothelium in the initiation and growth of plaque, a characteristic of atherosclerosis. One of the major challenges in carrier design for targeting cardiovascular diseases (CVD) is that carriers must be able to navigate the circulation system and efficiently marginate to the endothelium in order to interact with the target receptors. AREAS COVERED: This review draws on studies that have focused on the role of particle size, shape, and density (along with flow hemodynamics and hemorheology) on the localization of the particles to activated endothelial cell surfaces and vascular walls under different flow conditions, especially those relevant to atherosclerosis. EXPERT OPINION: Generally, the size, shape, and density of a particle affect its adhesion to vascular walls synergistically, and these three factors should be considered simultaneously when designing an optimal carrier for targeting CVD. Available preliminary data should encourage more studies to be conducted to investigate the use of nano-constructs, characterized by a sub-micrometer size, a non-spherical shape, and a high material density to maximize vascular wall margination and minimize capillary entrapment, as carriers for targeting CVD.

Integrity signals

Registry

Crossref · 10.1080/17425247.2017.1316262

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The present model could not fully represent the complexity of biological systems (e.g., lack of plasma proteins or circulating blood cells) that are known to affect NP properties and nanobio interactions.

    “Although the present model could not fully represent the complexity of biological systems (e.g., lack of plasma proteins or circulating blood cells) that are known to a ff ect NP properties and nanobio interactions, 70,71”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ta, H. T., Truong, N. P., Whittaker, A. K., Davis, T. P., & Peter, K.
Affiliations
  • The University of Queensland (AU)
  • Monash University (AU)
  • University of Warwick (GB)
  • Baker Heart and Diabetes Institute (AU)
Corresponding author
  • Ta, Hang T.
  • Peter, Karlheinz
Venue
Expert Opinion on Drug Delivery
Published
2017-04-13
Volume
15
Issue
1
Pages
33-45
ISSN
  • 1742-5247 (ISSN-L)
  • 1744-7593
OpenAlex
W2604413746
Cited by
105
References
112
Citations by year
2026: 11 · 2025: 7 · 2024: 10 · 2023: 13 · 2022: 9 · 2021: 17 · 2020: 13 · 2019: 12 · 2018: 9 · 2017: 4
FWCI
0.76
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Drug Delivery (publishedVersion)
  • PubMed (publishedVersion)
  • Griffith Research Online (submittedVersion)
  • Warwick Research Archive Portal (University of Warwick) (submittedVersion)
Funders
  • Australian Research Council (CE140100036)
  • National Health and Medical Research Council (APP1037310, FT0992210)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Blood properties and coagulation
Keywords
vascular wall, atherosclerosis, particle size, particle shape, particle density, hemorheology, endothelial cell adhesion, cardiovascular disease
MeSH terms
Coronary Artery Disease, Coronary Vessels, Densitometry, Drug Carriers, Endothelium, Vascular, Hemodynamics, Humans, Particle Size, Drug Delivery Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review